Nasdaq Sldb News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Solid Biosciences (NASDAQ:SLDB – Get Free Report) and Ambrx Biopharma (NYSE:AMAM – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, profitability and valuation. Profitability This table compares Solid Biosciences and […]

Shares of Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) have received a consensus rating of “Buy” from the six research firms that are covering the company, Marketbeat reports. Six analysts have rated the stock with a buy recommendation. The average 1 year price target among brokers that have updated their coverage on the stock […]

Solid Biosciences (NASDAQ:SLDB – Get Free Report) and Immunovant (NASDAQ:IMVT – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability. Profitability This table compares Solid Biosciences and Immunovant’s net […]

Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) CFO Kevin Tan sold 3,935 shares of the company’s stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $8.20, for a total value of $32,267.00. Following the sale, the chief financial officer now directly owns 9,308 shares in the […]

Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) COO David T. Howton sold 5,367 shares of Solid Biosciences stock in a transaction on Monday, December 4th. The stock was sold at an average price of $2.78, for a total value of $14,920.26. Following the sale, the chief operating officer now owns 7,684 shares in the […]